These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 16123806

  • 21. Cripto-1: an embryonic gene that promotes tumorigenesis.
    de Castro NP, Rangel MC, Nagaoka T, Salomon DS, Bianco C.
    Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
    [Abstract] [Full Text] [Related]

  • 22. Decrypting the role of Cripto in tumorigenesis.
    Shen MM.
    J Clin Invest; 2003 Aug; 112(4):500-2. PubMed ID: 12925690
    [Abstract] [Full Text] [Related]

  • 23. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
    Kelber JA, Shani G, Booker EC, Vale WW, Gray PC.
    J Biol Chem; 2008 Feb 22; 283(8):4490-500. PubMed ID: 18089557
    [Abstract] [Full Text] [Related]

  • 24. Cripto-1: an oncofetal gene with many faces.
    Bianco C, Strizzi L, Normanno N, Khan N, Salomon DS.
    Curr Top Dev Biol; 2005 Feb 22; 67():85-133. PubMed ID: 15949532
    [Abstract] [Full Text] [Related]

  • 25. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
    Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, Gray PC.
    Oncogene; 2009 Jun 18; 28(24):2324-36. PubMed ID: 19421146
    [Abstract] [Full Text] [Related]

  • 26. Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.
    Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, Seftor RE, Salomon DS, Hendrix MJ.
    Breast Dis; 2008 Jun 18; 29():91-103. PubMed ID: 19029628
    [Abstract] [Full Text] [Related]

  • 27. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
    Kumar A, Novoselov V, Celeste AJ, Wolfman NM, ten Dijke P, Kuehn MR.
    J Biol Chem; 2001 Jan 05; 276(1):656-61. PubMed ID: 11024047
    [Abstract] [Full Text] [Related]

  • 28. Ras pathway signals are required for notch-mediated oncogenesis.
    Fitzgerald K, Harrington A, Leder P.
    Oncogene; 2000 Aug 31; 19(37):4191-8. PubMed ID: 10980592
    [Abstract] [Full Text] [Related]

  • 29. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
    Yan YT, Liu JJ, Luo Y, E C, Haltiwanger RS, Abate-Shen C, Shen MM.
    Mol Cell Biol; 2002 Jul 31; 22(13):4439-49. PubMed ID: 12052855
    [Abstract] [Full Text] [Related]

  • 30. Role of Cripto-1 in stem cell maintenance and malignant progression.
    Bianco C, Rangel MC, Castro NP, Nagaoka T, Rollman K, Gonzales M, Salomon DS.
    Am J Pathol; 2010 Aug 31; 177(2):532-40. PubMed ID: 20616345
    [Abstract] [Full Text] [Related]

  • 31. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S, Casanova I, Farré L, Mazo A, Capellà G, Mangues R.
    Cancer Res; 2000 Dec 01; 60(23):6750-6. PubMed ID: 11118062
    [Abstract] [Full Text] [Related]

  • 32. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
    Miharada K, Karlsson G, Rehn M, Rörby E, Siva K, Cammenga J, Karlsson S.
    Ann N Y Acad Sci; 2012 Aug 01; 1266():55-62. PubMed ID: 22901256
    [Abstract] [Full Text] [Related]

  • 33. Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.
    D'Andrea D, Liguori GL, Le Good JA, Lonardo E, Andersson O, Constam DB, Persico MG, Minchiotti G.
    J Cell Biol; 2008 Feb 11; 180(3):597-605. PubMed ID: 18268105
    [Abstract] [Full Text] [Related]

  • 34. Cripto-1: an extracellular protein - connecting the sequestered biological dots.
    Klauzinska M, Bertolette D, Tippireddy S, Strizzi L, Gray PC, Gonzales M, Duroux M, Ruvo M, Wechselberger C, Castro NP, Rangel MC, Focà A, Sandomenico A, Hendrix MJ, Salomon D, Cuttitta F.
    Connect Tissue Res; 2015 Feb 11; 56(5):364-80. PubMed ID: 26327334
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development.
    Reissmann E, Jörnvall H, Blokzijl A, Andersson O, Chang C, Minchiotti G, Persico MG, Ibáñez CF, Brivanlou AH.
    Genes Dev; 2001 Aug 01; 15(15):2010-22. PubMed ID: 11485994
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM.
    Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556
    [Abstract] [Full Text] [Related]

  • 38. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.
    Saloman DS, Bianco C, Ebert AD, Khan NI, De Santis M, Normanno N, Wechselberger C, Seno M, Williams K, Sanicola M, Foley S, Gullick WJ, Persico G.
    Endocr Relat Cancer; 2000 Dec 17; 7(4):199-226. PubMed ID: 11174844
    [Abstract] [Full Text] [Related]

  • 39. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

  • 40. Role of the cripto (EGF-CFC) family in embryogenesis and cancer.
    Bianco C, Normanno N, Salomon DS, Ciardiello F.
    Growth Factors; 2004 Sep 28; 22(3):133-9. PubMed ID: 15518236
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.